VYNE Therapeutics Inc Sustainability Reports
VYNE Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on developing proprietary therapies for immuno-inflammatory conditions. Its pipeline includes novel bromodomain extra-terminal (BET) inhibitors designed for local or targeted administration.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
4 reports from 2017 to 2025